Shephard Mpofu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sanofi, Pfizer, Acelyrin and more—Chutes & Ladders

Sanofi, Pfizer, Acelyrin and more—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesCity ofUnited kingdomEric greenAnita scheuberMichael harveyMax bayerAndrew baumMarc beckerDanielle meyrickMichael chenSteve labkoffJulie oshaughnessyShephard mpofuStacy lindborg

ACELYRIN, INC Scales for Continued Late-Stage Growth with The Appointment of Dr Shephard Mpofu as Senior Vice President of Development

ACELYRIN, INC Scales for Continued Late-Stage Growth with The Appointment of Dr Shephard Mpofu as Senior Vice President of Development
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomHidradenitis suppurativaTyler marciniakLos angelesGodfrey huggins school of medicineRoyal college of physicians united kingdomExchange commissionUniversity of zimbabweSenior leadership teamContinued late stage growthShephard mpofuSenior vice presidentGlobal leadPsoriatic arthritisAxial spondyloarthritisSenior leadership

Final positive results of Zolgensma® trial for SMA published

After nearly all spinal muscular atrophy (SMA) patients treated with Zolgensma® achieved key motor milestones, Novartis announces publication of full SPR1NT results.

Shephard mpofuEuropean academy for neurology virtual congressMuscular dystrophy associationWorld health organizationNature medicineEuropean academyNeurology virtual congressDystrophy associationSenior vice presidentChief medical officerNovartis gene therapies

Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine

Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Shephard mpofuWorld health organizationNovartis gene

Novartis data again demonstrate age-appropriate development

Children with three copies of SMN2 treated presymptomatically achieved age-appropriate milestones, including standing and walking; required no ventilatory.

United statesShephard mpofuKevin straussExchange commissionMuscular dystrophy associationEuropean academy for neurologyWorld health organizationVirtual congressDystrophy associationScientific conferenceMedical directorSpecial childrenChief medical officerNovartis geneEuropean academyGene therapies